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Abstract
OBJECTIVE: To explore the mechanistic effects of
Yajieshaba (YJSB) on enhanced liver detoxification.
METHODS: The effects of YJSB on alanine amino-
transferase (ALT) and aspartate aminotransferase
(AST) were assayed in five acute chemical liver inju-
ry models [carbon tetrachloride (CCl4), D-galactos-
amine (D-Glan), 4-acetamidophenol (AAP), thio-
acetamide (TAA) and 1-naphthyl isothiocyanate
(ANIT)]. Sleep latency and sleep time of pentobarbi-
tal sodium were tested in control mice and CCl4
model miceafter oral YJSB administration. The ef-
fects of YJSB on drug metabolism enzymes of liver
microsomes were tested in control rats and CCl4
model rats. The levels of cytochrome P450
(CYP450 ) and Cyt b5 in liver microsomes were as-
sayed using the method by Omura and Sato, and
activities of erythromycin N-demethylase (ERD)
and aminopyrine N-demethyl (ADM) were evaluat-
ed by Nash colorimetry. Probe substrate-based
high performance liquid chromatography (HPLC)
methods were established for CYP3A4 and
CYP1A2.
RESULTS: The level of serum ALT was reduced by
YJSB at 3.51 g/kg in the five models as follows:
CCl4 > D-Glan, AAP, ANIT > TAA. YJSB treatment did
not reduce the level of serum AST. YJSB at 3.51 g/kg
prolonged the sleep latency in control mice and
shortened the sleep time of control mice and CCl4
model mice. For control rats, YJSB at 2.43 g/kg in-
creased the levels of CYP450 and Cyt b5 and in-
duced the activities of ERD and ADM; for liver inju-
ries induced by CCl4 in rats, YJSB at 2.43 g/kg in-
creasedthe levels of CYP450 and Cyt b5. These re-
sults suggest that YJSB at 2.43 g/kg induces
CYP3A4 and CYP1A2.
CONCLUSION: These results suggest that YJSB en-
hanced liver detoxification and the mechanisms
may be partially related to CYP3A4 and CYP1A2 in-
duction.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
The cytochrome P450 (CYP)-dependent mixedfunc-
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tion oxidase system, which comprises a superfamilyof
enzymes, plays a major role in themetabolism of both
xenobiotics and endogenouschemicals. Many chemi-
cals including therapeutic agents and other xenobiotics
have beenshown to either induce or inhibit CYP iso-
form-dependent enzyme activities. With the develop-
ment of anew therapeutic agent, it is important to as-
certainwhether the compound is either an induceror an
inhibitor of xenobiotic metabolizing enzymes to mini-
mize potential drug interactions.1
Although almost all tissues in thebody possess cyto-
chrome P450 enzymes, the liver isthe main target or-
gan of study with the highestconcentrations of cyto-
chrome P450s.2 Among numerous CYPs identified to
date, five human CYP enzymes (CYP1A2, CYP2C9,
CYP2D6, CYP2E1, and CYP3A4) are responsible for
approximately 80% of CYP-mediated drug metabo-
lism.3 CYP3A4 is considered the most important be-
cause CYP3A4 constitutes 30%-50% of the total CYP
content in human liver, and many drugs are substrates
for CYP3A4.1,4,5 Moreover, CYP1A2 is an impor-
tant subfamily of human cytochrome p450 enzymes, it
constitutes 15% of total CYP content in human liver.
A cocktail study isconsidered auseful approach because
it allows the simultaneous determination of several
CYP activities using a mixture of probes in a single
test, while intra-subject variability is minimized over
time. However, this strategy has two major difficulties:
the choice of the probes to avoid the occurrence of met-
abolic interactions when administered simultaneously
and the availability of an appropriate analyti-
calmethod.6 The probe drugs selected for the present-
study were dapsone and caffeine.
Yajieshaba (YJSB), prepared by Xishuangbanna Hospi-
tal of Dai Indigenous Medicine (Xishuangbanna, Chi-
na), has a long history of clinical use.Anexperiment in-
dicated that mice, which were treated at 88.8 g/kg (the
maximum dose of YJSB, equivalent to 1776-fold of the
adult dose) by single intragastric administration, were
generally in good condition without death, and the col-
or, shape, and size of major organs were normal at 14
days afterintragastricadministration. These results
showed that the customary dose (YJSB at 3.51 g/kg)
for clinical use was safe.
YJSB is commonly used in clinical detoxification by
Dai doctors, but thedetoxification mechanism is not
clear.Therefore, the purpose of our study was to ex-
plore the effects and possible mechanism of YJSB on
enhanced liver detoxification , which provide the phar-
macological experimental basis for clinically safe use.
MATERIALS ANDMETHODS
Animals
Adult male Sprague-Dawley rats of specific pathogen
free grade [5 months old, weighing (300 ± 50) g] and
adult male Kunming miceof SPF grade [3 months old,
weighing (18 ± 2) g] were used in the experiments.The
rats were purchased from the Institue of Laboratory
Animal, Sichuan Academy of Medical Sciences [labora-
tory animal certificate: scxk (chuang) 2008-24, Sich-
uan, China]and fed in the Laboratory Animal Center
of Yunnan University of Traditional Chinese Medi-
cine. The study was approved by the experimental ani-
mal ethics committee of Yunnan University of Tradi-
tional Chinese Medicine.
Preparation of Yajieshaba
YJSB consisted of Daibaijie (Dregea Sinensis Hemsl.)
18 g, Baiyangjie (Arundina Graminifolia D. Don Ho-
chr.) 14 g, Heitaohan (Arcangelisia Loureiri Pier. Diels)
7 g, Dengheihan (Mappianthus Iodoides H.- M.) 6 g,
and Binhao (Clerodendrum Chinese Osfeck Mabferlley)
5 g.
YJSB was purchased from Dai Hospital of Xishuang-
banna. An aqueous extract of YJSB was prepared ac-
cording to the following procedures: a medical solution
was heated to boiling and then decocted for 30 min
with three times (v/w) distilled water. The filtrate was
then collected. The residue was decocted for 20 min
with two times (v/w) distilled water, and then the fil-
trate was collected. The residue was decocted again for
20 min with two times (v/w) distilled water, and then
the filtrate was collected again and mixed with the pre-
viously collected filtrate,condensed and dried at 60 ℃ .
The yield of dried powder was 25.3% of the original
herbs. The doses were prepared as a powder and then
suspended in distilled water. In this paper, all doses of
the YJSB are expressed as gram of the original herbs
per kilogram body weight.
Acute chemical liver injury
Two hundred male Kunming mice were randomly di-
vided into four groups (n = 50 per group) bythe ran-
dom number table method: A (control), B (model), C
(model + 3.51 g/kg YJSB) and D (model + 0.39 g/kg
YJSB). YJSB was orally administeredfor 7 days (once/
day).Six days after administration, the liver injury mod-
els induced by CC14, D-Glan, AAP, TAA, and ANIT
were established at 0.5h after administration, except
for group A. The five different mice models of liver in-
jury in groups B-D were replicated at 0.5 h after the
6-day administration.The activities of alanine amino-
transferase (ALT) and aspartate aminotransferase
(AST) were assayed.
Sleep time of pentobarbital sodium
Thirty male Kunming mice were randomly divided in-
to three groups (n = 10 per group) bythe random num-
ber table method: A (control), B (3.51 g/kg YJSB) and
C (0.39 g/kg YJSB). YJSB was orally administered for
7 days (once/day).
Forty male Kunming mice were randomly divided into
four groups (n = 10 per group) by the random number
table method: D (control), E (CCl4 model), F (CCl4 +
198
JTCM |www. journaltcm. com April 15, 2015 |Volume 35 | Issue 2 |
Duan XH et al. / Experimental Study
3.51 g/kg YJSB), and G (CCl4 + 0.39 g/kg YJSB).
YJSB was orally administeredfor 7 days (once/day).
The mouse models of liver injury in groups E-G were
replicatedby intraperitoneal injection of 0.2% CCl4
(0.1 mL/10 g) every 0.5 h after the 6-day administra-
tion.
Sodium pentobarbital was intraperitoneally injected
(75 mg/kg) in groups A-G every 0.5 h after the last ad-
ministration. Sleep latency and sleep time were assayed
in groups A-G.
Drug metabolizing enzymes of liver microsomes
Twenty-four adult male Sprague-Dawley rats were ran-
domly divided into three groups (n = 8 per group) by
the random number table method: A (control), B
(2.43 g/kg YJSB) and C (0.27 g/kg YJSB). YJSB was
orally administeredfor14 days (once/day).
Thirty-two adult male Sprague-Dawley rats were ran-
domly divided into four groups (n = 8 per group)
bythe random number table method: D (control), E
(CCl4 model), F (CCl4 + 2.43 g/kg YJSB) and G (CCl4
+ 0.27 g/kg YJSB). YJSB was orally administered for
14 days (once/day). The groups E-G rat models of liver
injury were replicated by intraperitoneal injection 5%
CCl4 (1 mL/100 g) every 0.5 h after 13 days of admin-
istration.
Liver microsomes were prepared by the CaCl2 precipita-
tion method, and protein concentration was measured
by the BCA method. The levels of CYP450 and Cyt
b5 in the liver microsomes were assayed by the method
of Omura and Sato, and activities of ERD and ADM
were tested using Nash colorimetry.
Cytochrome P450 isoforms CYP1A2 and CYP3A4
Chemicals and reagents: methanol (Tianjin Concord
Science Co., Ltd., Tianjin, China) and ammonium ace-
tate (Adamas-beta) was of HPLC grade. HPLC-grade
water used throughout the study was obtained from a
Milli-Q Reagent Water System (Millipore, MA, USA).
Metronidazole dapsone and caffeine were from The Na-
tional Institute for the Control of Pharmaceutical and
Biological Products (Beijing, China).
Apparatus and chromatography: all analytical proce-
dureswere performed using a Dionex UltiMate 3000
HPLC system (Dionex Company, Sunnyvale, CA,
USA) and a Waters 2487 photodiode array detector
(Waters Company, Milford, MA, USA). The analytical
column was a Thermo C18 column (250 mm × 4.6 mm
i.d., 5 µm particle size; Thermo Company, Waltham,
MA, USA). The mobile phase comprised of methanol
(20 mol/L ammonium acetate) (85∶15, v/v). The de-
tector was set to a wavelength of 265 nm. The injec-
tion volume was 50 µL, and the flow rate was 1.0 mL/
min. The column temperature was controlled at 40℃.
Preparation of standard and quality control samples
Stock solutions of dapsone and caffeine were prepared
in acetonitrile at a concentration of 10 mg/mL. The
standard working solution was then further diluted
with acetonitrile to provide a series of standard solu-
tions at desired concentrations. All solutions were
stored at﹣20 ℃ and brought to room temperature be-
fore use. The calibration standard working solutions or
quality control (QC) samples were prepared from the
stock solution with pooled rat blank plasma. The QC
samples were separately prepared at low, medium, and
high concentration levels.
Sample preparation
Twenty-four adult male Sprague-Dawley rats were ran-
domly divided into four groups (n = 6 per group)
bythe random number table method: A (dapsone), B
(dapsone + 2.43 g/kg YJSB), C (caffeine) and D (caf-
feine + 2.43 g/kg YJSB). YJSB at 2.43 g/kg was orally-
administered for 14 days (once/day). At 12 h after the
last administration, dapsone (10 mg/kg) and caffeine
(10 mg/kg) were intravenously administered.
Method validation
Calibration curve: calibrationstandards of dapsone
(0.25-16 µg/mL) and caffeine (0.5-16 µg/mL) were
prepared and assayed. The calibration curve was con-
structed by plotting the X = As (peak area of cocktail
drug)/Ai (peak area of metronidazole) versus the con-
centration (Y) of the calibration standard. Linear regres-
sion analysis was used to determine the slope, inter-
cept, and correlation coefficient.7
Precision: intra-day precision was evaluated from repli-
cate analysis (n = 6) of the QC samples at different
concentrations on the same day. Inter-day accuracy
and precision were also assessed from the analysis of
the same QC samples on six consecutive days in repli-
cate (n = 6). QC samples were analyzed against the cali-
bration curves. Mean, standard deviation, and relative
standard deviation (RSD) were determined.8
Recovery
The extraction recovery of dapsone and caffeine was
evaluated at three QC levels by comparing the peak ar-
eas from extracted tissuesamples with those found by
direct injection of standardsolutions at the same con-
centration.9
Pharmacokinetic study
For the pharmacokinetic study, dapsone and caffeine
were dissolved in saline at a dose of 10 mg/kg body
weight and intravenously administered by tail vein in-
jection. At predetermined intervals (5, 15, 30, 45, 60,
120, 300, 480, and 720 min), blood samples (approxi-
mately 0.35 mL) were collected from the retro-orbital
plexus into heparinized microfuge tubes. To a 350-µL
sample of rat plasma, after centrifugation for 10 min
and 3000 rpm at 4 ℃, 100 µL of the supernatant fluid
was transferred. A 100-µL aliquot of the supernatant
fluid and 500 µL acetonitrile were vortexed for 2 min
and centrifuged for 10 min at 7000 ×g at 4 ℃. The su-
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pernatant fluid was then transferred and dried with ni-
trogen. The residue was dissolved in 400 µL 10%meth-
anol, vortexed for 2 min and centrifuged for 10 min at
9000 rpm and 4 ℃ . A 50-µL aliquot of the solution
was injected into the HPLC system for analysis.10
Statistical analysis
One-way analysis of variance was performed with SPSS
18.0 (SPSS Inc., Chicago, IL, USA). Values were ex-
pressed as mean ± standard deviation ( xˉ ± s ). Statisti-
cal significance was determined at the level of P <0.05.
RESULTS
Effect on acute chemical liver injury
The serum ALT level of 3.51 g/kg YJSB was less than
that of the model group induced by CCl4, D-Galn,
AAP and ANIT (P <0.05). No significant difference
was observed with YJSB at 0.39 g/kg. No significant
difference was observed in the serum ALT level of
3.51 g/kg YJSB and 0.39 g/kg YJSB in the TAA-in-
duced injury model. No significant differences were ob-
served in the serum ASTl evel of 3.51 g/kg YJSB and
0.39 g/kg YJSB in the injury models induced by CC14,
D-Glan, AAP, TAA, and ANIT (Figure 1).
Effects onsleep time of pentobarbital sodium
After intraperitoneal injection of pentobarbital sodi-
um, YJSB at 3.51 g/kg YJSB prolonged sleep latency in
control mice (P < 0.01) and shortened the sleep time
of control mice and CCl4 model mice (P < 0.05). No
significant differences were observed with YJSB at
0.39 g/kg (Figure 2).
Effects ondrug metabolizing enzymes of liver
microsomes
For control rats, YJSB at 2.43 g/kg increased the levels
of CYP450 and Cyt b5 and induced the activities of
ERD and ADM (P < 0.05). For liver injury induced by
CCl4, YJSB at 2.43 g/kg increasedthe levels of CYP450
and Cyt b5 (P < 0.05)and hadno effect on the activi-
ties of ERD and ADMas illustrated in Figure 3.
Effects oncytochrome P450 isoforms CYP1A2 and
CYP3A4
Selectivity: under the above described conditions, the
HPLC chromatograms of blank plasma, blank plasma
spiked with metronidazole (100 µg/mL), dapsone
(4 µg/mL) and caffeine (8 µg/mL), plasma after intrave-
nous dapsone (10 mg/kg) and caffeine (10 mg/kg) are
shown in Figure 4.
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Figure1 Effect of YJSB on five acute chemical liver injury models
A: alanine aminotransferase; B: aspartate aminotransferase. Five different models (0.2% CC14, 800 mg/kg D-Glan, 500 mg/kg AAP,
100 mg/kg TAA, and 100 mg/kg ANIT) were replicated. YJSB-treated groups [YJSB-H (3.51 g/kg) and YJSB-L (0.39 g/kg)], bifendate
treated (200 mg/kg), and control treated with distilled water, administered one week. YJSB: Yajieshaba; CCl4: carbon tetrachloride;
D-Glan: D-galactosamine; AAP: 4-acetamidophenol; TAA: thioacetamide; ANIT: 1-naphthyl isothiocyanate. Data are presented as
the mean ± standard derviation (n = 10). Significant differences compared with the control (non- CC14, D-Glan, AAP, TAA and
ANIT-treated) group were designated as aP < 0.05 and with five different models (CCl4, D-Glan, AAP, TAA, and ANIT) as bP < 0.01 and
cP < 0.05.
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The retention times (RTs) of metronidazole, dapsone,
and caffeine in plasma were 7.2, 13.9, and 16.5 min,
respectively. The peak of the analyte was identified by
comparing its retention time with its standard. There
was no interfering peak within the elution times for ei-
ther reference standardsor tested samples.
Calibration curve: the linear regressions of dapsone
and caffeine in rat plasma were obtained using X = As
(peak area of cocktail drug) / Ai (peak area of metroni-
dazole) and the concentration (Y) of standard solu-
tions. The calibration curves for dapsone and caffeine
displayed good linearity (correlation coefficients >
0.99). The linear regression equations for the calibra-
tion curves in rat plasma were dapsone Y = 0.1753x −
0.0499 (r = 0.9972) and caffeine Y = 0.1108x −
0.0086 (r = 0.9968).
Precision: dapsone and caffeine plasma samples at
three concentration levels were analyzed for precision.
The data areshown in Table 1. The precision (RSD)
was less than 10% . These results indicated that the
present method had good precision.
Recovery: the extraction recovery data of dapsone and
caffeine from rat plasma are listed in Table 2. These da-
ta were obtained from six replicate analyses of the QC
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Figure 2 Effect of pentobarbital sodium on sleep time after oral administration of YJSB
A: non-CCl4-treated, significant differences comparedwith the control group were designated as aP <0.01. B: 0.2% CCl4-treated, sig-
nificant differences compared with CCl4 (model control) were designated as bP <0.05, and with the control group as cP <0.05.
YJSB-treated groups [YJSB-H (3.51 g/kg) and YJSB-L (0.39 g/kg)] and control treated with distilled water, administered one week.
YJSB: Yajieshaba. Data are presented as the mean ± standard deviation (n = 10).
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Figure 3 Effect of YJSB on drug metabolizing enzymes of liver microsomes
A: non-CCl4-treated, significant differences comparedwith the control group were designated as bP <0.05 and cP< 0.01. B: 0.2%
CCl4-treated, significant differences comparedwith the control group were designated as aP <0.05, with CCl4 (model control) as bP <
0.05 and cP <0.01. YJSB-treated groups [YJSB-H (2.43 g/kg) and YJSB-L (0.27 g/kg)] and control treated with distilled water, adminis-
tered one week. YJSB: Yajieshaba. Data are presented as the mean ± standard deviation (n = 8).
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samples at high, medium, and low concentrations.
These results show the mean extraction recoveries of
dapsone (98.4-106.5) and caffeine (95.0-102.0). These
results represented the acceptable recoveries of dapsone
and caffeine in rat plasma, indicating satisfactory, reli-
able, and valid results of the present method.
Pharmacokinetics
The method employed in this study yielded satisfacto-
ry results for the quantification of dapsone and caf-
feine in rat plasma after intravenous administration
of 10 mg/kg dapsone and caffeine. The mean plasma
concentration-time profiles of dapsone and caffeine are
presented in Figure5A and B. Pharmacokinetic analysis
of the concentration-time data wasperformed using
DAS 3.0 software.The t1/2 of dapsone and caffeine were
significantly less than the control group (P < 0.05),
and CL/F of caffeine was significantly higher than that
of the control group (P < 0.05) as illustrated in Table 3.
DISCUSSION
Acute chemical liver injury models induced by CCl4,
A
C
B
Figure 4 Chromatogram of the probe drug
A: blank plasma sample with metronidazole (internal standard); B: blank plasma sample with metronidazole (RT1 = 7.2 min), dap-
sone (RT2 = 13.9 min) and caffeine (RT3 = 16.5 min); C: plasma sample after intravenous administration of dapsone and caffeine.
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D-Glan, AAP, TAA, and ANIT are well known, and it
is important to screen drugs for hepatotoxicity. CCl4 is
a potent hepatotoxin producing centrilobular hepatic
necrosis and is widely used in animal models of hepato-
Spiked Concentration
(µg/mL)
Dapsone 0.25
2
8
Caffeine 0.5
4
16
Intra-day
Quantitated concentration (µg/mL)
0.260±0.020
2.300±0.120
7.850±0.170
0.510±0.020
4.220±0.110
15.760±0.310
RSD (%)
8.1
5.3
2.1
5.6
2.6
2.0
Inter-day
0.270±0.020
2.180±0.100
7.810±0.280
0.530±0.040
3.980±0.120
16.220±0.270
Quantitated concentration (µg/mL) RSD (%)
7.1
4.8
3.6
7.8
2.9
1.6
Note: RSD: relative standard deviation.
Table 1 Intra-day and inter-day precision of dapsone and caffeine (n = 6, xˉ ± s)
Table 2 Recoveries of dapsone and caffeine in rat plasma (n = 6, xˉ ± s)
Spiked concentration(µg/mL)
Dapsone 0.25
2
8
Caffeine 0.5
4
16
Quantitated concentration (µg/mL)
0.260±0.020
2.130±0.170
7.870±0.220
0.510±0.090
3.800±0.300
16.130±0.400
Recoveries (%)
104.0
106.5
98.4
102.0
95.0
100.8
Notes: t1/2: half-life time; V/F: apparent volume of dis-tribution; AUC: area under the curve; CL/F: clearance. YJSB: Yajieshaba. Values are
presented as the mean ± standard deviation (n = 6). Compared with the control group, aP < 0.05, bP <0.01.
Parameter
t1/2(h)
V/F (L/kg)
AUC (µg·h﹣1·mL﹣1)
CL/F (L·kg﹣1·h﹣1)]
Dapsone (CYP3A4, cytochrome P450 3A4)
Control
6.46±1.18
0.81±0.16
103.30±53.62
0.28±0.07
2.43 g/kg YJSB
4.19±1.45a
0.84±0.17
131.55±67.82
0.25±0.05
Caffeine (CYP1A2, cytochrome P450 1A2)
Control
5.86±1.65
1.95±0.21
100.49±55.60
0.27±0.05
2.43 g/kg YJSB
4.02±0.38a
1.76±0.52
85.66±46.86
0.36±0.03b
Table 3 Main pharmacokinetic parameters for dapsone and caffeine (n = 6, xˉ ± s)
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Figure 5 Dapsone and caffeine plasma concentration-time curve after intravenous injection in tail vein of rats
A: dapsone; B: caffeine. YJSB-treated group with YJSB (2.43 g/kg) and control treated with distilled water, administered one week.
Data are presented as the mean ± standard deviation (n = 6). YJSB: Yajieshaba; CL/F: clearance. The t1/2 of dapsone and caffeine
were significantly less than that of the control group (P < 0.05), and CL/F of caffeine was significantly higher than that of the con-
trol group (P < 0.01).
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toxicity. It is biotransformed into a trichloromethyl
free radical (CCl3· and/or CCl3OO·) by the cyto-
chrome P450 (CYP450) system in liver microsomes
andconsequently decreases the activities of antioxidant
enzymes, causes lipid peroxidation of membranes, and
leads to liver injury.11,12AAP is a safe and effective anal-
gesic when used at therapeutic levels. However, an over-
dose of AAP can induce severe hepatotoxicity in both
experimental animals and humans. Although there are
many processes involved with AAP toxicities, such as
covalent binding of the highlyreactive metabolite of
AAP to cellular macromolecules, lipid peroxidation, ox-
idationof critical sulfhydryl groups, and alteration of
calcium homeostasis, increasing evidence suggests that
oxidative stress contributes to AAP-induced liver inju-
ry.13,14 D-Glan, ANIT, and TAA are also frequently
used in liver injurystudies.15-17 Our results showed that
YJSB at 3.51 g/kg significantly reduced the serum ALT
level in the following injury models: CCl4 > D-Glan,
AAP, ANIT > TAA.
Pentobarbital sodiumismetabolized and inactivatedin
vivo by CYP450 enzymes, and the effects of medica-
tion on sleep can reflect the activity of CYP450 en-
zymes.18 We found that the YJSB at 3.51 g/kg pro-
longed sleep latency in control mice andshortened
sleep time of control mice and CCl4 model mice.
These results suggest that YJSB accelerates the metabo-
lism of pentobarbital sodium and induces the hepatic
drug metabolizing enzymes.
CYP450 and Cyt b5 total protein are important elec-
tron transfer systems in the drug metabolism pathway,
and changes in CYP450 and Cyt b5 levels can affect
the activity levels of enzymes, which have been in-
duced or inhibited.19,20 Studies have shown thatYJSB at
2.43 g/kg increased the levels of CYP450 and Cyt b5
of control rats and CCl4 model rats; the activity of en-
zymes was induced. The activities of CYP2E1 and
CYP3A4 were assayed by ADM and ERD activity.21,22
Our studies also showed that 2.43 g/kg YJSB induced
the activities of ERD and ADM in control rats. It
should be noted that interactions of YJSB in combina-
tion with other drugs might occur.
CYP450 enzymes represents the major drug metaboliz-
ing system in humans thataccounts for the metabolism
of most medications.23 Among numerous CYPs identi-
fied to date, CYP1A2 and CYP3A4 are responsible for
approximately 60% of the CYP-mediated drug metabo-
lism, which are very important subfamilies of human
cytochrome P450 enzymes.24,25 The doses of YJSB were
based on doses used in patients, and CYP1A2 and
CYP3A4 as the most important CYPs in humans were
selected as indexes.We hope that experimental results
are useful for clinical studies. Probe substrate-based
HPLC methods were established for CYP3A4 and
CYP1A2.26,27 The probe drugs selected for the present
study were dapsone (CYP3A4) and caffeine
(CYP1A2).6 The result suggests that 2.43 g/kg YJSB in-
duces CYP3A4 and CYP1A2.
In summary, these results demonstrate that YJSB
enhances liver detoxification, and the mechanism
may be partially related to CYP3A4 and CYP1A2
induction.
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